Endocrine · 2024
Practical consensus for the treatment and follow-up of primary aldosteronism: a multidisciplinary consensus document.
СтатьяConsensus StatementОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Araujo-Castro Marta, Ruiz-Sánchez Jorge Gabriel, Ramírez Paola Parra, Martín Rojas-Marcos Patricia, Aguilera-Saborido Almudena, Gómez Cerezo Jorge Francisco, López Lazareno Nieves, Torregrosa María Eugenia, Gorrín Ramos Jorge, Oriola Josep, Poch Esteban, Oliveras Anna, Méndez Monter José Vicente, Gómez Muriel Isabel, Bella-Cueto María Rosa, Mercader Cidoncha Enrique, Runkle Isabelle, Hanzu Felicia A
Аннотация
Primary aldosteronism (PA) is the most frequent cause of secondary hypertension and is associated with a higher cardiometabolic risk than essential hypertension. The aim of this consensus is to provide practical clinical recommendations for its surgical and medical treatment, pathology study and biochemical and clinical follow-up, as well as for the approach in special situations like advanced age, pregnancy and chronic kidney disease, from a multidisciplinary perspective, in a nominal group consensus approach of experts from the Spanish Society of Endocrinology and Nutrition (SEEN), Spanish Society of Cardiology (SEC), Spanish Society of Nephrology (SEN), Spanish Society of Internal Medicine (SEMI), Spanish Radiology Society (SERAM), Spanish Society of Vascular and Interventional Radiology (SERVEI), Spanish Society of Laboratory Medicine (SEQC(ML)), Spanish Society of Anatomic-Pathology and Spanish Association of Surgeons (AEC).